# Electroacupuncture may improve endometrial receptivity in controlled ovarian hyperstimulation mice by activating AVP neurons

**Authors:** Tiantian Ma, Qian Li, Junwei Li, Yi Fang, Yan Zan, Yu Zhuang, Qian Zhu, Liangjun Xia, Youbing Xia

PMC · DOI: 10.3389/fendo.2026.1765673 · Frontiers in Endocrinology · 2026-02-23

## TL;DR

Electroacupuncture may improve womb readiness in mice undergoing fertility treatments by activating brain cells that regulate daily rhythms.

## Contribution

This study identifies a novel mechanism by which electroacupuncture enhances endometrial receptivity in COH mice through activation of AVP neurons in the SCN.

## Key findings

- EA improves uterine morphology and restores circadian gene expression in COH mice.
- EA increases AVP expression in the SCN and reduces progesterone levels during the implantation window.
- EA's effects on endometrial receptivity are diminished when AVP antagonists are co-administered.

## Abstract

Controlled ovarian hyperstimulation (COH) can lead to reduced endometrial receptivity during the window of implantation (WOI) and disrupted expression of endometrial clock genes. This study aimed to explore the potential mechanisms by which electroacupuncture (EA) improves endometrial receptivity in COH mice, focusing on the regulation of central and peripheral clock genes within the circadian system.

Experiment 1 included three groups of mice: control (CTR), COH, and EA. Each group was further subdivided into six subgroups according to sampling time. Tissue samples were collected at ZT12-ZT8 on days 4–5 of pregnancy (D4-5). Uterine morphology was examined, and serum estradiol (E2) and progesterone (P4) levels, endometrial receptivity markers, and mRNA expression of circadian clock genes in the hypothalamic-pituitary-ovarian-uterine (HPOU) axis were assessed. In Experiment 2, mice were assigned to five groups: CTR, COH, EA, agonist (AG), and antagonists and EA (AT+EA). All mice were sacrificed at ZT4 on day 5 of pregnancy (D5). We measured arginine vasopressin (AVP) neuropeptide levels in the suprachiasmatic nucleus (SCN); serum E2 and P4 levels; mRNA expression of circadian clock genes in the HPOU axis; and both protein and mRNA levels of endometrial receptivity markers.

EA ameliorates uterine morphological abnormalities in COH mice during the WOI. Furthermore, EA upregulates the mRNA expression of the endometrial receptivity markers, decreases serum P4 levels, and restores the circadian rhythmicity of HPOU axis clock genes. The most significant intergroup differences regarding endometrial receptivity markers were observed at WOI-ZT4. At this time point, both EA and AG interventions increased AVP neuropeptide expression, suppressed serum P4 levels, modulated HPOU axis clock gene expression, and elevated the expression of endometrial receptivity markers at the protein and mRNA levels. Notably, the co-administration of AT with EA attenuated the therapeutic efficacy of EA at this stage.

EA may enhance endometrial receptivity in COH mice at the WOI-ZT4 stage by activating AVP neurons in the SCN and restoring the circadian expression pattern of clock genes along the HPOU axis. These findings provide experimental evidence supporting a circadian mechanism by which EA may enhance endometrial function during assisted reproductive processes.

## Linked entities

- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Clock (clock circadian regulator) [NCBI Gene 12753] {aka 5330400M04Rik, KAT13D}, Avp (arginine vasopressin) [NCBI Gene 11998] {aka Vp, Vsp}, Hoxa10 (homeobox A10) [NCBI Gene 15395] {aka Hox-1.8, Hoxa-10}, Cry1 (cryptochrome circadian regulator 1) [NCBI Gene 12952] {aka Phll1}, Per1 (period circadian clock 1) [NCBI Gene 18626] {aka Hftm, Per, m-rigui, mPer1}, Alb (albumin) [NCBI Gene 11657] {aka Alb-1, Alb1, BCL001, BCL002, BPL001}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Sp6 (trans-acting transcription factor 6) [NCBI Gene 83395] {aka 1110025J03Rik, Epfn, Klf14}, Csnk1e (casein kinase 1, epsilon) [NCBI Gene 27373] {aka CK1epsilon, CKIe, KC1epsilon, tau}, Bmal1 (basic helix-loop-helix ARNT like 1) [NCBI Gene 11865] {aka Arnt3, Arntl, BMAL1b, MOP3, bHLHe5, bmal1b'}, Spp1 (secreted phosphoprotein 1) [NCBI Gene 20750] {aka 2AR, Apl-1, BNSP, BSPI, Bsp, ETA-1}, Avpr1a (arginine vasopressin receptor 1A) [NCBI Gene 54140] {aka AVPR, Avpr1, V1a, V1aR}, CSF3 (colony stimulating factor 3) [NCBI Gene 1440] {aka C17orf33, CSF3OS, GCSF}, Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Maoa (monoamine oxidase A) [NCBI Gene 17161] {aka 1110061B18Rik}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, Fbxl3 (F-box and leucine-rich repeat protein 3) [NCBI Gene 50789] {aka FBK, Fbl3a, Fbxl3a, Ovtm, Play68}, Cry2 (cryptochrome circadian regulator 2) [NCBI Gene 12953] {aka D130054K12Rik}
- **Diseases:** COH (MESH:D016471), Infertility (MESH:D007246), WOI (MESH:D057873), endometrial injury (MESH:D014591), twitching (MESH:D013746), ovarian and uterine dysfunction (MESH:D010049), inflammatory (MESH:D007249), edema (MESH:D004487)
- **Chemicals:** hematoxylin (MESH:D006416), H2O2 (MESH:D006861), (Phe2 (-), HE (MESH:D006371), SR49059 (MESH:C082134), lipids (MESH:D008055), paraformaldehyde (MESH:C003043), Chloroform (MESH:D002725), citrate (MESH:D019343), DAPI (MESH:C007293), DAB (MESH:C000469), luteinizing hormone (MESH:D007986), P4 (MESH:C015586), polyvinylidene difluoride (MESH:C024865), follicle-stimulating hormone (MESH:D005640), Paraffin (MESH:D010232), Polymer (MESH:D011108), E2 (MESH:D004958), xylene (MESH:D014992), Trizol (MESH:C411644), water (MESH:D014867), ethanol (MESH:D000431), AT (MESH:D001246), biotin (MESH:D001710), SDS (MESH:D012967), isopropanol (MESH:D019840), Progesterone (MESH:D011374)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12968007/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12968007/full.md

## References

88 references — full list in the complete paper: https://tomesphere.com/paper/PMC12968007/full.md

---
Source: https://tomesphere.com/paper/PMC12968007